- info@novaerus.ie
- +353 (1) 255 1536
To evaluate the efficacy of the NV1050 in reducing airborne Staphylococcus epidermidis bacteria, a surrogate for methicillin-resistant Staphylococcus aureus (MRSA).
The test environment was a 30 m3 test chamber, located in the Novaerus microbiology laboratory. During the testing, the NV1050 device was placed inside the chamber at the centre, with the air inlet facing towards the door of the chamber. The NV1050 device was tested at maximum airflow, speed setting 5. The test chamber was controlled for temperature and humidity at 25ºC and 50% relative humidity.
The NV105 achieved a microbial cell reduction of 99.94% of Staphylococcus epidermidis, a surrogate for methicillin-resistant Staphylococcus aureus (MRSA), within 15 minutes of operation.
About Us
Novaerus is on a mission to reduce indoor airborne pollutants that lead to infection, allergies, asthma, and odour.
The patented plasma NanoStrike technology used in Novaerus portable devices was invented in Ireland in 2006.
Novaerus Devices
Stay Connected to Novaerus
To keep up to date with all developments and for the latest research and scientifically proven results please follow us on LinkedIn, Facebook and Youtube.
